| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |